Johanna Friedl-Naderer

Companies

• Dyne Therapeutics, Inc.Chief Commercial Officer Sep 3, 2024 to now¹
• VIR BiotechnologyChief operating officer Feb 24, 2023 to Mar 7, 2023²
• VIR BiotechnologyChief Business Officer, Global Mar 8, 2022 to Mar 8, 2022³

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• DTDyne Therapeutics, Inc. DYN152,897 shares⁴$2.3M at $14.99Sep 8, 2026
• VBVIR Biotechnology VIR148,518 shares⁵$1.5M at $10.23Mar 3, 2023

As of each latest filing. The line shows shares held over time.

Recent filings

• Sep 8, 2026Sold 185 shares at $18.88 of Dyne Therapeutics, Inc.⁴
• Sep 4, 2026Sold 900 shares at $24.35 of Dyne Therapeutics, Inc.⁴
• Aug 13, 2026Sold 226 shares at $26.28 of Dyne Therapeutics, Inc.⁶
• Jun 16, 2026Sold 145 shares at $18.33 of Dyne Therapeutics, Inc.⁷
• May 13, 2026Sold 228 shares at $18.36 of Dyne Therapeutics, Inc.⁸
• Mar 5, 2026Sold 148 shares at $14.90 of Dyne Therapeutics, Inc.⁹
• Feb 12, 2026Granted 60,000 shares of Dyne Therapeutics, Inc.¹⁰
• Dec 5, 2025Sold 144 shares at $20.72 of Dyne Therapeutics, Inc.¹¹
• Sep 5, 2025Sold 144 shares at $13.41 of Dyne Therapeutics, Inc.¹²
• Sep 4, 2025Sold 894 shares at $13.27 of Dyne Therapeutics, Inc.¹²
• Jun 5, 2025Sold 146 shares at $13.35 of Dyne Therapeutics, Inc.¹³
• Mar 13, 2025Sold 143 shares at $12.12 of Dyne Therapeutics, Inc.¹⁴
• Dec 4, 2024Granted 37,800 shares of Dyne Therapeutics, Inc.¹⁵
• Sep 3, 2024Granted 58,400 shares of Dyne Therapeutics, Inc.¹⁶
• Mar 3, 2023Sold 1,482 shares at $22.82 of VIR Biotechnology⁵
• Feb 22, 2023Granted 60,000 shares of VIR Biotechnology¹⁷
• Mar 2, 2022Granted 90,000 shares of VIR Biotechnology¹⁸